Litcius/Paper detail

B-cell depleters attenuate the humoral response to SARS-CoV-2 vaccines in multiple sclerosis patients: A case-control study

William L. Conte

2021Multiple Sclerosis and Related Disorders12 citationsDOIOpen Access PDF

Topics & Concepts

MedicineImmunologyAntibodyOcrelizumabAntibody responseFingolimodMultiple sclerosisAntibody titerAntigenInternal medicineTiterRituximabSARS-CoV-2 and COVID-19 ResearchMultiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders
B-cell depleters attenuate the humoral response to SARS-CoV-2 vaccines in multiple sclerosis patients: A case-control study | Litcius